Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Manabe, A.
Right arrow Articles by Nakazawa, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Manabe, A.
Right arrow Articles by Nakazawa, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
Journal of Clinical Oncology, Vol 19, Issue 13 (July), 2001: 3182-3187
© 2001 American Society for Clinical Oncology

Delay of the Diagnostic Lumbar Puncture and Intrathecal Chemotherapy in Children With Acute Lymphoblastic Leukemia Who Undergo Routine Corticosteroid Testing: Tokyo Children’s Cancer Study Group Study L89-12

By A. Manabe, M. Tsuchida, R. Hanada, K. Ikuta, Y. Toyoda, Y. Okimoto, K. Ishimoto, H. Okawa, A. Ohara, T. Kaneko, K. Koike, T. Sato, K. Sugita, F. Bessho, Y. Hoshi, M. Maeda, A. Kinoshita, T. Saito, Y. Tsunematsu, S. Nakazawa

From the Tokyo Children’s Cancer Study Group; Department of Pediatric Hematology-Oncology, Institute of Medical Science, and Department of Pediatrics, University of Tokyo; Department of Pediatrics, Juntendo University; Department of Pediatrics, Tokyo Medical and Dental University; First Department of Pediatrics, Toho University; Department of Hematology-Oncology, Tokyo Metropolitan Kiyose Children’s Hospital; Department of Pediatrics, Jikei University; Department of Pediatrics, Nippon Medical School; Department of Pediatrics, Keio University; and Departments of Environmental Epidemiology and Hematology, National Children’s Hospital, Tokyo; Department of Pediatrics, Ibaraki Children’s Hospital, Mito; Department of Hematology-Oncology, Saitama Children’s Medical Center, Iwatsuki; Department of Pediatrics, Yokohama City University; and Department of Oncology, Kanagawa Children’s Medical Center, Yokohama; Department of Hematology-Oncology, Chiba Children’s Hospital; and Department of Pediatrics, Chiba University, Chiba; Department of Pediatrics, University of Shinshu, Matsumoto; Department of Pediatrics, Dokkyo Medical School, Tochigi; and Department of Pediatrics, Yamanashi Medical University, Kofu, Japan.

Address reprint requests to Atsushi Manabe, MD, Department of Pediatric Hematology-Oncology, Institute of Medical Science, University of Tokyo, 4-6-1, Shirokanedai, Minato-ku, Tokyo 108-8639, Japan; email: manabe{at}ims.u-tokyo.ac.jp

PURPOSE: To determine the effects of eliminating initial lumbar punctures in 418 consecutively treated children with acute lymphoblastic leukemia (ALL).

PATIENTS AND METHODS: Patients were enrolled onto a trial conducted in central Japan between 1989 and 1992. Treatment consisted of standard four-drug induction therapy followed by a risk-based intensification phase, reinduction therapy, late intensification, and remission maintenance therapy (total of 104 weeks). The initial lumbar puncture, with an intrathecal injection of chemotherapy, was performed after 1 week of prednisolone sensitivity testing (day 8). End points included response to prednisolone, CNS status at the time of the day 8 lumbar puncture, subsequent adverse events in CNS and bone marrow, and event-free survival (EFS).

RESULTS: The remission induction rate was 93.1% with a 6-year EFS rate (± SE) of 68.7% ± 2.4%, which is similar to historical results for patients who received their diagnostic lumbar puncture and first instillation of intrathecal chemotherapy on day 0. Overall, 84.5% of the patients had good responses to prednisolone, whereas 15.5% had poor responses. Clinical outcome was strikingly better for the good responders (6-year EFS, 74.1% ± 2.5% compared with 40.1% ± 6.4% for patients with poor responses), suggesting that omission of intrathecal chemotherapy did not alter the predictive value of drug sensitivity testing. Eighteen patients experienced CNS relapse as their first adverse event (cumulative risk, 5.1%; 95% confidence interval, 2.7% to 7.4%), coincident with reports from groups using conventional strategies of CNS clinical management. Bleeding into the CSF at the time of the day 8 lumbar puncture was apparent in 29 cases (8.1%), but leukemic blasts were identified in only two.

CONCLUSION: Delay of the initial lumbar puncture and intrathecal injection of chemotherapy seems to be feasible in children with ALL. Further controlled evaluations are needed to establish the validity of this conclusion.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
haematolHome page
A. Manabe, A. Ohara, D. Hasegawa, K. Koh, T. Saito, N. Kiyokawa, A. Kikuchi, H. Takahashi, K. Ikuta, Y. Hayashi, et al.
Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15
Haematologica, August 1, 2008; 93(8): 1155 - 1160.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
C.-H. Pui
Toward Optimal Central Nervous System-Directed Treatment in Childhood Acute Lymphoblastic Leukemia
J. Clin. Oncol., January 15, 2003; 21(2): 179 - 181.
[Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2001 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online